[18F]FE-PE2I PET: ein neuer Biomarker für das idiopathische Parkinson-Syndrom

• Antragsteller: Dr. Joachim Brumberg
• Fachliche Zuordnung: Nuklearmedizin, Strahlentherapie, Strahlenbiologie ; Klinische Neurologie; Neurochirurgie und Neuroradiologie
• Förderung: Förderung von 2019 bis 2021
• Projektkennung: Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 422567340

• Erstellungsjahr: 2021

Zusammenfassung der Projektergebnisse

Keine Zusammenfassung vorhanden

Projektbezogene Publikationen (Auswahl)

• Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy. Neurobiol Dis. 2021
  Brumberg J, Kuzkina A, Lapa C, Mammadova S, Buck A, Volkmann J, Sommer C, Isaias IU, Doppler K.
  
• Brain metabolic alterations herald falls in patients with Parkinson's disease. Ann Clin Transl Neurol. 2020
  Isaias IU, Brumberg J, Pozzi NG, Palmisano C, Canessa A, Marotta G, Volkmann J, Pezzoli G
  
• Detection Rate of 68Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy. Biomedicines. 2020; 8:511
  Brumberg J, Beckl M, Dierks A, Schirbel A, Krebs M, Buck A, Kübler H, Lapa C, Seitz AK
  
• Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. npj Parkinson's Disease. 2020; 6:1
  Brumberg J, Schröter N, Blazhenets G, Frings L, Volkmann J, Lapa C, Jost WH, Isaias IU, Meyer PT
  
• Simplified quantification of [18F]-FE-PE2I PET in Parkinson’s disease: discriminative power, testretest reliability and longitudinal validity during early peak and late pseudo-equilibrium. J Cereb Blood Flow Metab. 2020
  Brumberg J, Kerstens V, Cselényi Z, Svenningsson P, Sundgren M, Fazio P, Varrone A
  
• Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity. JAMA Netw Open. 2021; 1:4(4):e217083
  Linz C, Brands RC, Herterich T, Hartmann S, Muller-Richter U, Kubler AC, Haug L, Kertels O, Bley TA, Dierks A, Buck AK, Lapa C, Brumberg J
  
• Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus. Neurology. 2021
  Todisco M, Zangaglia R, Minafra B, Pisano P, Trifiro G, Bossert I, Pozzi NG, Brumberg J, Ceravolo R, Isaias IU, Fasano A, Pacchetti C
  
• Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus. Mov Disord. 2021; 26:124-132
  Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifiro G, Ceravolo R, Vitali P, Isaias IU, Fasano A, Pacchetti C.